» Articles » PMID: 24978596

Serum Adiposity-induced Biomarkers in Obese and Lean Children with Recently Diagnosed Autoimmune Type 1 Diabetes

Overview
Publisher Wiley
Date 2014 Jul 1
PMID 24978596
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

Background/objective: Obesity increases the risk of cardiovascular disease and diabetic complications in type 1 diabetes. Adipokines, which regulate obesity-induced inflammation, may contribute to this association. We compared serum adipokines and inflammatory cytokines in obese and lean children with new-onset autoimmune type 1 diabetes.

Subjects And Methods: We prospectively studied 32 lean and 18 obese children (age range: 2-18 yr) with new-onset autoimmune type 1 diabetes and followed them for up to 2 yr. Serum adipokines [leptin, total and high molecular weight (HMW) adiponectin, omentin, resistin, chemerin, visfatin], cytokines [interferon (IFN)-gamma, interleukin (IL)-10, IL-12, IL-6, IL-8, and tumor necrosis factor (TNF)-alpha] and C-reactive protein (CRP) were measured at a median of 7 wk after diagnosis (range: 3-16 wk).

Results: Lean children were 71.9% non-Hispanic White, 21.9% Hispanic, and 6.3% African-American, compared with 27.8, 55.6, and 16.7%, respectively, for obese children (p = 0.01). Compared with lean children, obese children had significantly higher serum leptin, visfatin, chemerin, TNF-alpha and CRP, and lower total adiponectin and omentin after adjustment for race/ethnicity and Tanner stage. African-American race was independently associated with higher leptin among youth ≥10 yr (p = 0.007). Leptin levels at onset positively correlated with hemoglobin A1c after 1-2 yr (p = 0.0001) independently of body mass index, race/ethnicity, and diabetes duration. Higher TNF-alpha was associated with obesity and female gender, after adjustment for race/ethnicity (p = 0.0003).

Conclusion: Obese children with new-onset autoimmune type 1 diabetes have a proinflammatory profile of circulating adipokines and cytokines that may contribute to the development of cardiovascular disease and diabetic complications.

Citing Articles

Serological markers of exocrine pancreatic function are differentially informative for distinguishing individuals progressing to type 1 diabetes.

Williams M, Grace C, Posgai A, McGrail K, Brusko M, Haller M BMJ Open Diabetes Res Care. 2025; 13(1.

PMID: 39755561 PMC: 11749058. DOI: 10.1136/bmjdrc-2024-004655.


Pro- and anti-inflammatory cytokines are the game-changers in childhood obesity-associated metabolic disorders (diabetes and non-alcoholic fatty liver diseases).

Ullah A, Singla R, Batool Z, Cao D, Shen B Rev Endocr Metab Disord. 2024; 25(4):783-803.

PMID: 38709387 DOI: 10.1007/s11154-024-09884-y.


Excessive BMI is associated with higher C-peptide level at recognition but also with its greater loss in two years clinical observation in children with new onset type 1 diabetes.

Kurpiewska E, Ciezki S, Jamiolkowska-Sztabkowska M, Polkowska A, Starosz A, Grubczak K Front Immunol. 2023; 14:1176403.

PMID: 37180128 PMC: 10174309. DOI: 10.3389/fimmu.2023.1176403.


Can type 1 diabetes be an unexpected complication of obesity?.

Oboza P, Ogarek N, Olszanecka-Glinianowicz M, Kocelak P Front Endocrinol (Lausanne). 2023; 14:1121303.

PMID: 37065759 PMC: 10102381. DOI: 10.3389/fendo.2023.1121303.


Relationships between Body Weight Status and Serum Levels of Adipokine, Myokine and Bone Metabolism Parameters in Healthy Normal Weight and Thin Children.

Ambroszkiewicz J, Chelchowska M, Mazur J, Rowicka G, Gajewska J J Clin Med. 2022; 11(14).

PMID: 35887780 PMC: 9320693. DOI: 10.3390/jcm11144013.


References
1.
Jialal I, Devaraj S, Kaur H, Adams-Huet B, Bremer A . Increased chemerin and decreased omentin-1 in both adipose tissue and plasma in nascent metabolic syndrome. J Clin Endocrinol Metab. 2013; 98(3):E514-7. DOI: 10.1210/jc.2012-3673. View

2.
Khan U, Wang D, Sowers M, Mancuso P, Everson-Rose S, Scherer P . Race-ethnic differences in adipokine levels: the Study of Women's Health Across the Nation (SWAN). Metabolism. 2012; 61(9):1261-9. PMC: 3404256. DOI: 10.1016/j.metabol.2012.02.005. View

3.
Kaminski B, Klingensmith G, Beck R, Tamborlane W, Lee J, Hassan K . Body mass index at the time of diagnosis of autoimmune type 1 diabetes in children. J Pediatr. 2012; 162(4):736-740.e1. DOI: 10.1016/j.jpeds.2012.09.017. View

4.
Liu L, Lawrence J, Davis C, Liese A, Pettitt D, Pihoker C . Prevalence of overweight and obesity in youth with diabetes in USA: the SEARCH for Diabetes in Youth study. Pediatr Diabetes. 2009; 11(1):4-11. DOI: 10.1111/j.1399-5448.2009.00519.x. View

5.
Shah A, Dolan L, Lauer A, Davis C, Dabelea D, Daniels S . Adiponectin and arterial stiffness in youth with type 1 diabetes: the SEARCH for diabetes in youth study. J Pediatr Endocrinol Metab. 2012; 25(7-8):717-21. PMC: 4343317. DOI: 10.1515/jpem-2012-0070. View